Browsing Tag
Bulletin
Small savings rates 44-77 bps lower than formula: RBI Bulletin
The current returns on India’s small savings schemes have slipped below the formula prescribed for determining their rates by 44 to 77 basis points (bps), despite a 10 to 30 bps increase…
Meta is shutting down Bulletin newsletter, TikTok is the ‘reason’ –…
Facebook-parent company Meta is shutting down Bulletin, its newsletter platform that allows avid readers to subscribe and have access to content from contributors like Canadian journalist…
Shatrughan Sinha urges AIIMS release health bulletin for Raju Srivastava: ‘Very…
Shatrughan Sinha has expressed his concerns over the health of comedian Raju Srivastava and urged AIIMS, Delhi to issue health bulletins for him, Raju has been admitted to the hospital for…
Le Québec obtient une note de C au bulletin sur les politiques en matière d’alcool en…
Restaurants Canada vient de publier une édition spéciale COVID-19 de son rapport Relever le débit dans laquelle le Québec est appelé à faire preuve de plus d’initiative en ce qui concerne…
Worst of inflation may be behind us, RBI staff say in July 2022 Bulletin
The pace of rise in prices in India is on…
43rd edition of V.K. Pahuja swimming bulletin released
The 42nd edition of the V.K. Pahuja swimming bulletin was released by the former Union Sports Minister JItendra Singh here on Thursday.The 450-page bulletin, spread over six interesting…
Unfolding global developments pose downside risks for Indian economy, RBI says
The Reserve Bank of India in its March 2022 Bulletin has said that the ongoing geopolitical crisis, i.e, the Russia-Ukraine war, has heightened the uncertainty clouding the global…
Bulletin on Adulteration of Saffron and Saffron Extracts Published by ABC-AHP-NCNPR…
AUSTIN, Texas, March 14, 2022 (GLOBE NEWSWIRE) -- The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has released a Botanical Adulterants Prevention Bulletin on saffron …
Minerva Neurosciences Announces Publication of Roluperidone Phase 3 Study Results in…
WALTHAM, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat…